chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore injection site left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore injection site left arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B2A) for COVID-19 vaccination.     The patient's past medical history included Tooth extraction. Concomitant products included IBUPROFEN from 19-Apr-2021 to an unknown date for Tooth extraction.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore injection site left arm). At the time of the report, VACCINATION SITE PAIN (Sore injection site left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Tremor, Vaccination site inflammation
Clinical narrative: inflammation of injection site; Pain of injection site; More difficulty breathing than normal; hands were trembling; Dizziness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (More difficulty breathing than normal), TREMOR (hands were trembling), VACCINATION SITE INFLAMMATION (inflammation of injection site), DIZZINESS (Dizziness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Hypertension, Anxiety, Cholesterol, Multiple sclerosis, Pollen allergy, Sun sensitivity and Smoker. Concomitant products included GABAPENTIN and MULTI VITAMIN & MINERAL for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Fatigue). On 24-Apr-2021, the patient experienced DYSPNOEA (More difficulty breathing than normal) and TREMOR (hands were trembling). On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (inflammation of injection site) and VACCINATION SITE PAIN (Pain of injection site). At the time of the report, DYSPNOEA (More difficulty breathing than normal), TREMOR (hands were trembling), VACCINATION SITE INFLAMMATION (inflammation of injection site), DIZZINESS (Dizziness), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included paracetamol and an anti-inflammatory drug.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: inflammation of injection site; Pain of injection site; More difficulty breathing than normal; hands were trembling; Dizziness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (More difficulty breathing than normal), TREMOR (hands were trembling), VACCINATION SITE INFLAMMATION (inflammation of injection site), DIZZINESS (Dizziness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Hypertension, Anxiety, Cholesterol, Multiple sclerosis, Pollen allergy, Sun sensitivity and Smoker. Concomitant products included GABAPENTIN and MULTI VITAMIN & MINERAL for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Fatigue). On 24-Apr-2021, the patient experienced DYSPNOEA (More difficulty breathing than normal) and TREMOR (hands were trembling). On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (inflammation of injection site) and VACCINATION SITE PAIN (Pain of injection site). At the time of the report, DYSPNOEA (More difficulty breathing than normal), TREMOR (hands were trembling), VACCINATION SITE INFLAMMATION (inflammation of injection site), DIZZINESS (Dizziness), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included paracetamol and an anti-inflammatory drug.
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-016540 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Additional information received on 26 Apr 2021. No additional information provided.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016540:dose 1
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive tested for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive tested for COVID-19) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.      Medical history was not provided.     On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive tested for COVID-19). The patient was treated with AZITHROMYCIN at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL 12 HOUR) at a dose of 1 dosage form. At the time of the report, SARS-COV-2 TEST POSITIVE (Positive tested for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was treated with vitamins. Concomitant medications were not reported.   This case was linked to MOD-2021-090196 (Patient Link).
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose started bleeding; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nose started bleeding) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced EPISTAXIS (Nose started bleeding). At the time of the report, EPISTAXIS (Nose started bleeding) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient wanted to know if she needs to go to the hospital or not.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Gastric disorder, Malaise
Clinical narrative: Does not feel good; Stomach problems and is a mess today; This spontaneous case was reported by a consumer and describes the occurrence of GASTRIC DISORDER (Stomach problems and is a mess today) and MALAISE (Does not feel good) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE for an unknown indication.    On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced GASTRIC DISORDER (Stomach problems and is a mess today). On 26-Apr-2021, the patient experienced MALAISE (Does not feel good). At the time of the report, GASTRIC DISORDER (Stomach problems and is a mess today) and MALAISE (Does not feel good) outcome was unknown. Not Provided          Treatment details included Gasex and Pepto bismol.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain in extremity
Clinical narrative: nauseous; had light dizziness; Arm was more sore; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous), DIZZINESS (had light dizziness) and PAIN IN EXTREMITY (Arm was more sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for Covid-19 Vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced NAUSEA (nauseous), DIZZINESS (had light dizziness) and PAIN IN EXTREMITY (Arm was more sore). On 13-Mar-2021, NAUSEA (nauseous), DIZZINESS (had light dizziness) and PAIN IN EXTREMITY (Arm was more sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for events include paracetamol. No lab data was provided by the reporter.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Dehydration, Dyspnoea, Pyrexia
Clinical narrative: dehydrated; heavy breathing; fever; This spontaneous case was reported by a patient and describes the occurrence of DEHYDRATION (dehydrated), DYSPNOEA (heavy breathing) and PYREXIA (fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031N21A and 008C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced DEHYDRATION (dehydrated), DYSPNOEA (heavy breathing) and PYREXIA (fever). At the time of the report, DEHYDRATION (dehydrated), DYSPNOEA (heavy breathing) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Apr-2021, Body temperature: 103.5 High.         Patient was very dehydrated even after having 2 bottles of water and a Gatorade. patient had heavy breathing but no trouble with breathing. He was concerned and wanted to know if he should go to the ER.  No concomitant medications were reported.  No treatment information was reported. Action taken with mRNA-1273 in response to the events was not Applicable
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: red injection site; swollen injection site; hard injection site; warm injection site 101.6ºF; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red injection site), VACCINATION SITE SWELLING (swollen injection site), VACCINATION SITE INDURATION (hard injection site) and VACCINATION SITE WARMTH (warm injection site 101.6ºF) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (red injection site), VACCINATION SITE SWELLING (swollen injection site), VACCINATION SITE INDURATION (hard injection site) and VACCINATION SITE WARMTH (warm injection site 101.6ºF). At the time of the report, VACCINATION SITE ERYTHEMA (red injection site), VACCINATION SITE SWELLING (swollen injection site), VACCINATION SITE INDURATION (hard injection site) and VACCINATION SITE WARMTH (warm injection site 101.6ºF) outcome was unknown. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sister was sick when it was time to get her 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sister was sick when it was time to get her 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sister was sick when it was time to get her 2nd dose). At the time of the report, ILLNESS (Sister was sick when it was time to get her 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Bedridden, Muscular weakness, Pyrexia, Therapeutic response unexpected
Clinical narrative: muscle weakness; All my hair is falling out after the first shot/going to get bald by end of this; I was in bed all the time/didn't even feel like getting up; I feel like I have aged 20-30 years after the Covid and the two vaccines; fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness), ALOPECIA (All my hair is falling out after the first shot/going to get bald by end of this), BEDRIDDEN (I was in bed all the time/didn't even feel like getting up), THERAPEUTIC RESPONSE UNEXPECTED (I feel like I have aged 20-30 years after the Covid and the two vaccines) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced MUSCULAR WEAKNESS (muscle weakness), ALOPECIA (All my hair is falling out after the first shot/going to get bald by end of this), BEDRIDDEN (I was in bed all the time/didn't even feel like getting up), THERAPEUTIC RESPONSE UNEXPECTED (I feel like I have aged 20-30 years after the Covid and the two vaccines) and PYREXIA (fever). At the time of the report, MUSCULAR WEAKNESS (muscle weakness), ALOPECIA (All my hair is falling out after the first shot/going to get bald by end of this), BEDRIDDEN (I was in bed all the time/didn't even feel like getting up), THERAPEUTIC RESPONSE UNEXPECTED (I feel like I have aged 20-30 years after the Covid and the two vaccines) and PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.   This case was linked to MOD-2021-090195 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: a little headache; a little fever; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (a little headache), PYREXIA (a little fever) and PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (a little headache), PYREXIA (a little fever) and PAIN IN EXTREMITY (sore arm). At the time of the report, HEADACHE (a little headache), PYREXIA (a little fever) and PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Diarrhoea, Fatigue, Feeding disorder
Clinical narrative: vaccination site pruritus; Diarrhea; Feeling tired; Chills with no fever; I don't feel well; Bone ache and pain; Not able to eat; Sluggish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I don't feel well), BONE PAIN (Bone ache and pain), FEEDING DISORDER (Not able to eat), SLUGGISHNESS (Sluggish) and DIARRHOEA (Diarrhea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021 at 4:00 PM, the patient experienced VACCINATION COMPLICATION (I don't feel well), BONE PAIN (Bone ache and pain), FEEDING DISORDER (Not able to eat), SLUGGISHNESS (Sluggish), FATIGUE (Feeling tired) and CHILLS (Chills with no fever). On 25-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (vaccination site pruritus). At the time of the report, VACCINATION COMPLICATION (I don't feel well), BONE PAIN (Bone ache and pain), FEEDING DISORDER (Not able to eat), SLUGGISHNESS (Sluggish), DIARRHOEA (Diarrhea), VACCINATION SITE PRURITUS (vaccination site pruritus), FATIGUE (Feeling tired) and CHILLS (Chills with no fever) had not resolved.            The patient had been drinking water and juice.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up received on 27-May-2021.outcome updated
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness, Vaccination complication, Vaccination site pruritus
Clinical narrative: vaccination site pruritus; Diarrhea; Feeling tired; Chills with no fever; I don't feel well; Bone ache and pain; Not able to eat; Sluggish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I don't feel well), BONE PAIN (Bone ache and pain), FEEDING DISORDER (Not able to eat), SLUGGISHNESS (Sluggish) and DIARRHOEA (Diarrhea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021 at 4:00 PM, the patient experienced VACCINATION COMPLICATION (I don't feel well), BONE PAIN (Bone ache and pain), FEEDING DISORDER (Not able to eat), SLUGGISHNESS (Sluggish), FATIGUE (Feeling tired) and CHILLS (Chills with no fever). On 25-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (vaccination site pruritus). At the time of the report, VACCINATION COMPLICATION (I don't feel well), BONE PAIN (Bone ache and pain), FEEDING DISORDER (Not able to eat), SLUGGISHNESS (Sluggish), DIARRHOEA (Diarrhea), VACCINATION SITE PRURITUS (vaccination site pruritus), FATIGUE (Feeling tired) and CHILLS (Chills with no fever) had not resolved.            The patient had been drinking water and juice.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up received on 27-May-2021.outcome updated
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 years old and received the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old and received the 1st dose) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical History information was reported.).    On 22-Apr-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old and received the 1st dose). On 22-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old and received the 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient was turning 18 years about 1.5 months from his first dose.  And also reported that the patient had No Known Drug Allergies (NKDA)  Concomitant medication were not provided by the reporter. Treatment medication were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21-JUN-2021 contains No Significant information
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Back pain, Headache, Joint swelling, Myalgia, Pain in extremity
Clinical narrative: Back Pain; ankle swelling; Foot pain; fever; Muscle pain, body pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), BACK PAIN (Back Pain) and JOINT SWELLING (ankle swelling) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), JOINT SWELLING (ankle swelling) and PAIN IN EXTREMITY (Foot pain). On an unknown date, the patient experienced BACK PAIN (Back Pain). At the time of the report, PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), BACK PAIN (Back Pain), JOINT SWELLING (ankle swelling) and PAIN IN EXTREMITY (Foot pain) outcome was unknown. Not Provided          No concomitant medication reported.  Treatment for the event include paracetamol and Ibuprofen.  Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Back Pain; ankle swelling; Foot pain; fever; Muscle pain, body pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), BACK PAIN (Back Pain) and JOINT SWELLING (ankle swelling) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), JOINT SWELLING (ankle swelling) and PAIN IN EXTREMITY (Foot pain). On an unknown date, the patient experienced BACK PAIN (Back Pain). At the time of the report, PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), BACK PAIN (Back Pain), JOINT SWELLING (ankle swelling) and PAIN IN EXTREMITY (Foot pain) outcome was unknown. Not Provided          No concomitant medication reported.  Treatment for the event include paracetamol and Ibuprofen.  Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: She also has some headache; Patient had fever at night after receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (She also has some headache) and PYREXIA (Patient had fever at night after receiving 2nd dose) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included OMEPRAZOLE for an unknown indication.    On 25-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced HEADACHE (She also has some headache) and PYREXIA (Patient had fever at night after receiving 2nd dose). At the time of the report, HEADACHE (She also has some headache) and PYREXIA (Patient had fever at night after receiving 2nd dose) outcome was unknown.            No treatment medication was provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Lethargy, Vaccination site pain
Clinical narrative: Brain fog" after 1st dose; Lethargy after 1st dose; When the plunger was injected into me felt an intense burning "like a match was in my arm"; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (Brain fog" after 1st dose), LETHARGY (Lethargy after 1st dose) and VACCINATION SITE PAIN (When the plunger was injected into me felt an intense burning "like a match was in my arm") in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID and ATENOLOL for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced FEELING ABNORMAL (Brain fog" after 1st dose), LETHARGY (Lethargy after 1st dose) and VACCINATION SITE PAIN (When the plunger was injected into me felt an intense burning "like a match was in my arm"). On 15-Feb-2021, FEELING ABNORMAL (Brain fog" after 1st dose), LETHARGY (Lethargy after 1st dose) and VACCINATION SITE PAIN (When the plunger was injected into me felt an intense burning "like a match was in my arm") had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-090267 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Feeling hot, Oropharyngeal discomfort, Paraesthesia oral
Clinical narrative: Light headed; Throat started to close a little bit; Metallic mouth taste; Feeling warm; Tongue had bubbles like when you drink something hot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed), OROPHARYNGEAL DISCOMFORT (Throat started to close a little bit), DYSGEUSIA (Metallic mouth taste), FEELING HOT (Feeling warm) and PARAESTHESIA ORAL (Tongue had bubbles like when you drink something hot) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced DIZZINESS (Light headed), OROPHARYNGEAL DISCOMFORT (Throat started to close a little bit), DYSGEUSIA (Metallic mouth taste), FEELING HOT (Feeling warm) and PARAESTHESIA ORAL (Tongue had bubbles like when you drink something hot). At the time of the report, DIZZINESS (Light headed), OROPHARYNGEAL DISCOMFORT (Throat started to close a little bit), DYSGEUSIA (Metallic mouth taste), FEELING HOT (Feeling warm) and PARAESTHESIA ORAL (Tongue had bubbles like when you drink something hot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow-up information included no new information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Influenza like illness, Injection site swelling, Myalgia, Pruritus
Clinical narrative: felt like had flu, but did not last long; flu without high fever; itching; low grade fever; achiness; redness in arm around injection site, up and down 2 to 3 inches; swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS, INFLUENZA, PRURITUS, PYREXIA, and MYALGIA in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Redness. The patient had hairline redness and itching that is gone. Concurrent medical conditions included Hypothyroidism. Concomitant products included SYNTHROID for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular)1 dosage form. On 10-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS, INFLUENZA, PRURITUS, PYREXIA, MYALGIA, VACCINATION SITE ERYTHEMA (redness in arm around injection site, up and down 2 to 3 inches), and INJECTION SITE SWELLING. The patient was treated with TYLENOL at a dose of 500 milligram. On 12-Apr-2021, INFLUENZA LIKE ILLNESS, INFLUENZA, PRURITUS, PYREXIA, MYALGIA, VACCINATION SITE ERYTHEMA (redness in arm around injection site, up and down 2 to 3 inches), and INJECTION SITE SWELLING had resolved.            The treatment includes Benadryl.   This case was linked to MOD-2021-090226.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema
Clinical narrative: felt like had flu, but did not last long; flu without high fever; itching; low grade fever; achiness; redness in arm around injection site, up and down 2 to 3 inches; swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS, INFLUENZA, PRURITUS, PYREXIA, and MYALGIA in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Redness. The patient had hairline redness and itching that is gone. Concurrent medical conditions included Hypothyroidism. Concomitant products included SYNTHROID for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular)1 dosage form. On 10-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS, INFLUENZA, PRURITUS, PYREXIA, MYALGIA, VACCINATION SITE ERYTHEMA (redness in arm around injection site, up and down 2 to 3 inches), and INJECTION SITE SWELLING. The patient was treated with TYLENOL at a dose of 500 milligram. On 12-Apr-2021, INFLUENZA LIKE ILLNESS, INFLUENZA, PRURITUS, PYREXIA, MYALGIA, VACCINATION SITE ERYTHEMA (redness in arm around injection site, up and down 2 to 3 inches), and INJECTION SITE SWELLING had resolved.            The treatment includes Benadryl.   This case was linked to MOD-2021-090226.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Dehydration, Dizziness, Dysarthria, Fatigue
Clinical narrative: several allergies; dehydrated; fatigue; slurred speech; Dizzy feeling on and off; Slurred speech; elevated blood pressure and pulse rate; elevated blood pressure and pulse rate; Felt like things were zooming; craving for salt and chips; Hyper feeling; Arm is a little tender; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy feeling on and off), VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling) and MULTIPLE ALLERGIES (several allergies) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (wheat and gluton) and Drug allergy (Iodine dye and sulphur).    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling) and TENDERNESS (Arm is a little tender). On 22-Apr-2021, the patient experienced DIZZINESS (Dizzy feeling on and off), DEHYDRATION (dehydrated), FATIGUE (fatigue), DYSARTHRIA (slurred speech), DYSARTHRIA (Slurred speech), BLOOD PRESSURE INCREASED (elevated blood pressure and pulse rate) and HEART RATE INCREASED (elevated blood pressure and pulse rate). On an unknown date, the patient experienced MULTIPLE ALLERGIES (several allergies). At the time of the report, DIZZINESS (Dizzy feeling on and off), VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling), MULTIPLE ALLERGIES (several allergies), DEHYDRATION (dehydrated), FATIGUE (fatigue), DYSARTHRIA (slurred speech), TENDERNESS (Arm is a little tender), DYSARTHRIA (Slurred speech), BLOOD PRESSURE INCREASED (elevated blood pressure and pulse rate) and HEART RATE INCREASED (elevated blood pressure and pulse rate) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Multiple allergies, Psychomotor hyperactivity, Salt craving, Tenderness
Clinical narrative: several allergies; dehydrated; fatigue; slurred speech; Dizzy feeling on and off; Slurred speech; elevated blood pressure and pulse rate; elevated blood pressure and pulse rate; Felt like things were zooming; craving for salt and chips; Hyper feeling; Arm is a little tender; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy feeling on and off), VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling) and MULTIPLE ALLERGIES (several allergies) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (wheat and gluton) and Drug allergy (Iodine dye and sulphur).    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling) and TENDERNESS (Arm is a little tender). On 22-Apr-2021, the patient experienced DIZZINESS (Dizzy feeling on and off), DEHYDRATION (dehydrated), FATIGUE (fatigue), DYSARTHRIA (slurred speech), DYSARTHRIA (Slurred speech), BLOOD PRESSURE INCREASED (elevated blood pressure and pulse rate) and HEART RATE INCREASED (elevated blood pressure and pulse rate). On an unknown date, the patient experienced MULTIPLE ALLERGIES (several allergies). At the time of the report, DIZZINESS (Dizzy feeling on and off), VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling), MULTIPLE ALLERGIES (several allergies), DEHYDRATION (dehydrated), FATIGUE (fatigue), DYSARTHRIA (slurred speech), TENDERNESS (Arm is a little tender), DYSARTHRIA (Slurred speech), BLOOD PRESSURE INCREASED (elevated blood pressure and pulse rate) and HEART RATE INCREASED (elevated blood pressure and pulse rate) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: several allergies; dehydrated; fatigue; slurred speech; Dizzy feeling on and off; Slurred speech; elevated blood pressure and pulse rate; elevated blood pressure and pulse rate; Felt like things were zooming; craving for salt and chips; Hyper feeling; Arm is a little tender; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy feeling on and off), VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling) and MULTIPLE ALLERGIES (several allergies) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (wheat and gluton) and Drug allergy (Iodine dye and sulphur).    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling) and TENDERNESS (Arm is a little tender). On 22-Apr-2021, the patient experienced DIZZINESS (Dizzy feeling on and off), DEHYDRATION (dehydrated), FATIGUE (fatigue), DYSARTHRIA (slurred speech), DYSARTHRIA (Slurred speech), BLOOD PRESSURE INCREASED (elevated blood pressure and pulse rate) and HEART RATE INCREASED (elevated blood pressure and pulse rate). On an unknown date, the patient experienced MULTIPLE ALLERGIES (several allergies). At the time of the report, DIZZINESS (Dizzy feeling on and off), VISUAL IMPAIRMENT (Felt like things were zooming), SALT CRAVING (craving for salt and chips), PSYCHOMOTOR HYPERACTIVITY (Hyper feeling), MULTIPLE ALLERGIES (several allergies), DEHYDRATION (dehydrated), FATIGUE (fatigue), DYSARTHRIA (slurred speech), TENDERNESS (Arm is a little tender), DYSARTHRIA (Slurred speech), BLOOD PRESSURE INCREASED (elevated blood pressure and pulse rate) and HEART RATE INCREASED (elevated blood pressure and pulse rate) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced MYALGIA (body aches) and HEADACHE (headache). On 26-Apr-2021, MYALGIA (body aches) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. The patient however took an unspecified treatment medication for the events.
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Cough). At the time of the report, COUGH (Cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: Back pain; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) and PAIN IN EXTREMITY (Arm pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain) and PAIN IN EXTREMITY (Arm pain). At the time of the report, BACK PAIN (Back pain) and PAIN IN EXTREMITY (Arm pain) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications have been reported.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Receiving the second dose of the vaccine after day 36 from the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving the second dose of the vaccine after day 36 from the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving the second dose of the vaccine after day 36 from the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving the second dose of the vaccine after day 36 from the first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17-year-old female patient received the first dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old female patient received the first dose of Moderna COVID-19 vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old female patient received the first dose of Moderna COVID-19 vaccine). On 12-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old female patient received the first dose of Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs and treatment medications were reported.   This case was linked to MOD21-081893, US-MODERNATX, INC.-MOD-2021-090693 (E2B Linked Report).; Sender's Comments:  MOD21-081893:crosslinked US-MODERNATX, INC.-MOD-2021-090693:crosslinked